We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Molly Coddington

Molly Coddington profile page

Senior Writer and Newsroom Team Lead

 at Technology Networks


Molly reports on various scientific topics, covering the latest breaking news and writing long-form pieces. In 2020, she created the Teach Me in 10 video series, where weekly guests discuss and teach a scientific concept in less than 10 minutes. Before joining Technology Networks in 2019, Molly worked as a clinical research associate in the NHS and as a freelance science writer. She has a first-class honors degree in neuroscience from the University of Leeds and received a Partnership Award for her efforts in science communication.


Education


University of Leeds  


Awards & Certifications


Georgina Henry Award for Digital Innovation Nominee

Lord Laidlaw Scholarship Recipient, University of Leeds

Partnership Award, University of Leeds


Accreditations


Neuroscience, BSc (Hons) recognised by the University of Leeds


Areas of Expertise



Got a Question for Molly Coddington?


Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Molly Coddington
Total: 968
News

Unraveling DNA Methylation Patterns Eases Introduction of Foreign DNA Into Host Cells

DNA methylation is catalyzed by a group of enzymes known as methyltransferases, which strategically decorate DNA with methyl groups in specific patterns. In a new study, scientists have developed a pipeline that allows for the identification of which enzyme causes which specific methylation pattern.
Article

Pressure to Fight Vaccine Hesitancy As Measles Cases Soar

The UK has lost its measles-elimination status. New York have removed nonmedical exemptions from school vaccination requirements. Italy have made a number of vaccines mandatory. Here, we explore how global health authorities are tackling the issue of vaccine hesitancy as the number of measles cases continues to rise.
Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata content piece image
Industry Insight

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.
Industry Insight

Agilent’s Latest Acquisition in the Cell Analysis Space: BioTek Instruments

Agilent Technologies Inc. recently announced it had signed an agreement to acquire BioTek Instruments, a global leader in life science instrumentation.
Article

Metabolic Pathways Are Altered in the Autistic Brain—Finding Could Lead to a Novel Diagnostic Test

A recent study found that there are differences in metabolite concentrations in healthy humans and individuals with Autism Spectrum Disorder (ASD). We spoke with Ilia Kurochkin, research scientist at the Skoltech Center for Neurobiology and Brain Restoration (CNBR), to learn more about the study and how the results could aid the development of a diagnostic tool for ASD.
Industry Insight

NRGene Are Taking Agricultural Research to the MAX

NRGene recently announced the launch of DeNovoMAX, an enhanced version of its flagship product DeNovoMAGIC, for whole genome assembly. As part of the DeNovo assembly product suite, DeNovoMAX aims to take agricultural research further by empowering breeding and maximizing agricultural yield. We spoke with Gal Ramot, Marketing Director at NRGene Ltd to learn about the applications of DeNovoMAX and how it has been built to crack the most "complex of genomes".
"MOSAIC" HIV Vaccine to be Tested in Thousands Globally content piece image
Article

"MOSAIC" HIV Vaccine to be Tested in Thousands Globally

A clinical trial testing a "mosaic" HIV vaccine is due to commence in September. The trial is pertinent considering a recent UNAIDS report expressed concerns that the pace of progress in reducing new HIV infections has slowed. This article discusses the plans for the trial and the current status of vaccine research in the field.
Cross-linking Mass Spectrometry: A Key Player in the Structural Biologist's Toolbox content piece image
Article

Cross-linking Mass Spectrometry: A Key Player in the Structural Biologist's Toolbox

Unsurprisingly, as the proteomics field has grown over recent years, in parallel, so has the size and complexity of the molecules that scientists want to study. The latest addition to the structural biologist's toolbox, cross-linking mass spectrometry (XL-MS), is helping researchers achieve these goals. In this article, we explore the current status of XL-MS with insights from two experts in the field, Professor Andrea Sinz and Dr Alexander Leitner.
Industry Insight

Wellness and Illness From a Precision Quantification Perspective

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.
Sculpting Never-ending Art Using Nature’s Natural Tools, Proteins content piece image
Article

Sculpting Never-ending Art Using Nature’s Natural Tools, Proteins

Proteins biological building blocks. Fibrous proteins such as keratins, collagens and elastins are built up from their individual components to form structures such as tendons, muscle fibers and bones. This is the natural course of biology – the instructions for assembly are organic. What happens when it is no longer nature guiding the building blocks, but rather, scientists? The borders of science and art become blurred.
Advertisement